Change in the Revenio Leadership Team: Kate Taylor to step down
Kurs
-2,62%
Likviditet
0,76 MEUR
Prenumeration
Kalender
| Est. tid* | ||
| 2026-10-29 | 08:00 | Kvartalsrapport 2026-Q3 |
| 2026-08-06 | 08:00 | Kvartalsrapport 2026-Q2 |
| 2026-04-28 | 08:00 | Kvartalsrapport 2026-Q1 |
| 2026-04-15 | N/A | Årsstämma |
| 2026-02-11 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-30 | - | Kvartalsrapport 2025-Q3 |
| 2025-08-07 | - | Kvartalsrapport 2025-Q2 |
| 2025-04-29 | - | Kvartalsrapport 2025-Q1 |
| 2025-04-11 | - | X-dag ordinarie utdelning REG1V 0.40 EUR |
| 2025-04-10 | - | Årsstämma |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-08 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-05 | - | X-dag ordinarie utdelning REG1V 0.38 EUR |
| 2024-04-04 | - | Årsstämma |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-10 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-24 | - | X-dag ordinarie utdelning REG1V 0.36 EUR |
| 2023-03-23 | - | Årsstämma |
| 2023-02-09 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-04 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-11 | - | X-dag ordinarie utdelning REG1V 0.34 EUR |
| 2022-04-08 | - | Årsstämma |
| 2022-02-10 | - | Bokslutskommuniké 2021 |
| 2021-10-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-05 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-23 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-18 | - | X-dag ordinarie utdelning REG1V 0.32 EUR |
| 2021-03-17 | - | Årsstämma |
| 2021-02-11 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-06 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-09 | - | X-dag ordinarie utdelning REG1V 0.30 EUR |
| 2020-06-08 | - | Årsstämma |
| 2020-04-22 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-15 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-16 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-21 | - | X-dag ordinarie utdelning REG1V 0.28 EUR |
| 2019-03-20 | - | Årsstämma |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-10-25 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-06 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-20 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-21 | - | X-dag ordinarie utdelning REG1V 0.78 EUR |
| 2018-03-20 | - | Årsstämma |
| 2018-02-15 | - | Bokslutskommuniké 2017 |
| 2017-10-26 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-07 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-22 | - | Årsstämma |
| 2017-04-20 | - | Kvartalsrapport 2017-Q1 |
| 2017-03-23 | - | X-dag ordinarie utdelning REG1V 0.74 EUR |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-10-31 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-08 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-25 | - | Kvartalsrapport 2016-Q1 |
| 2016-03-16 | - | X-dag ordinarie utdelning REG1V 0.70 EUR |
| 2016-03-15 | - | Årsstämma |
| 2016-02-15 | - | Bokslutskommuniké 2015 |
| 2015-10-27 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-10 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-24 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-20 | - | X-dag ordinarie utdelning REG1V 0.45 EUR |
| 2015-03-19 | - | Årsstämma |
| 2015-02-12 | - | Bokslutskommuniké 2014 |
| 2014-10-21 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-04 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-24 | - | Kvartalsrapport 2014-Q1 |
| 2014-03-21 | - | X-dag ordinarie utdelning REG1V 0.30 EUR |
| 2014-03-20 | - | Årsstämma |
| 2014-02-12 | - | Bokslutskommuniké 2013 |
| 2013-12-11 | - | X-dag bonusutdelning REG1V 0.3 |
| 2013-12-09 | - | Extra Bolagsstämma 2013 |
| 2013-10-22 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-28 | - | Kapitalmarknadsdag 2013 |
| 2013-08-05 | - | Kvartalsrapport 2013-Q2 |
| 2013-08-02 | - | X-dag bonusutdelning REG1V 0.12 |
| 2013-04-19 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-28 | - | Split REG1V 10:1 |
| 2013-03-22 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
| 2013-03-21 | - | Årsstämma |
| 2013-02-08 | - | Bokslutskommuniké 2012 |
| 2012-10-19 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-06 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-19 | - | Kvartalsrapport 2012-Q1 |
| 2012-03-29 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
| 2012-03-28 | - | Årsstämma |
| 2012-02-16 | - | Bokslutskommuniké 2011 |
| 2011-10-26 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-08 | - | Kvartalsrapport 2011-Q2 |
| 2011-04-27 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-01 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
| 2011-03-31 | - | Årsstämma |
| 2011-02-16 | - | Bokslutskommuniké 2010 |
| 2010-04-09 | - | X-dag ordinarie utdelning REG1V 0.01 EUR |
| 2009-04-16 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
| 2008-04-03 | - | X-dag ordinarie utdelning REG1V 0.04 EUR |
| 2007-04-09 | - | X-dag ordinarie utdelning REG1V 0.01 EUR |
| 2006-03-31 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
| 2005-04-01 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
| 2004-03-29 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
| 2003-03-24 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
| 2002-04-15 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Mid Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Revenio Group Corporation | Stock Exchange Release | January 15, 2026 at 14:30:00 EET
Leadership team member Dr. Kate Taylor (Vice President, Strategy and Business Development), will step down from her position by January 31, 2026. She has been based in Australia. The responsibilities of Vice President, Strategy and Business Development will be shared by the CEO Jouni Toijala and the Leadership Team.
“I would like to thank Kate for her significant contribution to advancing the Group’s strategy. Kate has played an important role in integrating Oculo, which she founded and which we acquired in 2021, into the Revenio Group. Her role has also been instrumental in building our software solutions business. I wish her every success in the future,” says Jouni Toijala, CEO of Revenio Group.
As of February 1, 2026, the Leadership Team of Revenio Group will consist of:
- Jouni Toijala, CEO
- John Floyd, Vice President, Sales
- Heli Huopaniemi, Vice President, Quality
- Ari Isomäki, Vice President, Operations
- Robin Pulkkinen, CFO
- Marco Rizzardo, Vice President, R&D
- Erkki Tala, Vice President, Products, Brand and Marketing
- Hanna Vuornos, Vice President, People and Culture
Further information
CEO Jouni Toijala, tel. +358 50 484 0085
jouni.toijala@revenio.fi
Distribution
Nasdaq Helsinki
Financial Supervisory Authority (FIN-FSA)
Key media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand.
In 2024, the Group’s net sales totaled EUR 103.5 million, with an operating profit of EUR 25.0 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.